Calcipotriol ointment vs. betamethasone 17‐valerate ointment in the treatment of lichen amyloidosis
Authors:
- Yong‐Kwang TayYTYong‐Kwang Tay
- Chee‐Leok GohCGChee‐Leok Goh
- From The National Skin CentreFCFrom The National Skin Centre
- SingaporeSISingapore
- 1 July 1999
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 38 (7) , 539-541
Abstract
Sixteen Asian patients (6 men and 10 women), in the age range 41–74 years, presenting clinically with symmetrically distributed lichen amyloidosis (LA) on the extremities, were enrolled in this double‐blind, right–left comparison pilot study to evaluate the efficacy of calcipotriol ointment (50 μg/g) vs. betamethasone 17‐valerate ointment (0.1%).This trial was conducted in a tertiary skin referral center in Singapore and consecutive patients with LA were recruited over a 3‐month period. Excluded were patients who were pregnant or lactating, patients with known contact allergy to either calcipotriol or topical steroid, patients with hypercalcemia, and those with significant hepatic or renal disease.After a washout period of 2 weeks, the ointments were applied separately to either the right or left extremities twice daily for a period of 12 weeks. Assessments were made at weeks 0, 4, 8, and 12 by both the physician and the patient. Treatment responses were assessed as follows: roughness (visual analog scale of 1–10, 1 being the least rough and 10 being the most rough), hyperpigmentation (visual analog scale of 1–10, 1 being the least hyperpigmented and 10 being the most hyperpigmented), and any adverse events. An additional parameter assessed by the patient was pruritus (visual analog scale of 1–10, 1 being the least pruritic and 10 being the most pruritic). Clinical photographs were taken during each review.For analyses of the responses, the mean roughness score is defined as the average sum of the roughness score of all patients for each treated side. Likewise the mean hyperpigmentation score and the mean pruritus score are defined as the average sum of hyperpigmentation and the average sum of pruritus, respectively. Any score differences observed between week 0 and week 12 within the two treatment groups were analyzed by Wilcoxon signed ranked test for statistical significance; differences in scores between the two treatment groups were analyzed by Mann–Whitney U‐test.Keywords
This publication has 13 references indexed in Scilit:
- Cytokeratins in primary cutaneous amyloidosisAustralasian Journal of Dermatology, 1998
- Efficacy, Tolerability, and Safety of Calcipotriol Ointment in Disorders of KeratinizationArchives of Dermatology, 1995
- Lack of effect of dimethyl sulphoxide (DMSO) on amyloid deposits in lichen amyloidosisBritish Journal of Dermatology, 1988
- Etretinate for the Treatment of Lichen AmyloidosisArchives of Dermatology, 1988
- Treatment of lichen amyloidosus by etretinateClinical and Experimental Dermatology, 1986
- Nodular primary localized cutaneous amyloidosis: Immunohistochemical evaluation and treatment with the carbon dioxide laserJournal of the American Academy of Dermatology, 1986
- Dermabrasion for Lichen AmyloidosusArchives of Dermatology, 1982
- Lichen AmyloidosusArchives of Dermatology, 1974
- LICHEN AMYLOIDOSUS IN SINGAPOREInternational Journal of Dermatology, 1971
- LICHEN AMYLOIDOSIS.British Journal of Dermatology, 1970